Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1791402-58-8

Post Buying Request

1791402-58-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1791402-58-8 Usage

General Description

Tert-butyl N-[(2R,3R)-2-methylpiperidin-3-yl]carbamate is a chemical compound that belongs to the class of carbamates, which are derived from carbamic acid. It is a derivative of N-tert-butylcarbamate and contains a piperidine ring. The compound is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various drugs and biologically active compounds. It has been studied for its potential as a central nervous system depressant and has shown promise in the treatment of certain neurological disorders. Additionally, it has potential applications in the development of agrochemicals and as a chemical intermediate in the manufacturing of other compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 1791402-58-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,9,1,4,0 and 2 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1791402-58:
(9*1)+(8*7)+(7*9)+(6*1)+(5*4)+(4*0)+(3*2)+(2*5)+(1*8)=178
178 % 10 = 8
So 1791402-58-8 is a valid CAS Registry Number.

1791402-58-8Relevant articles and documents

MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES

-

, (2021/11/06)

The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.

INHIBITORS OF BRUTON'S TYROSINE KINASE

-

Paragraph 00750, (2016/12/22)

Disclosed herein are reversible and irreversible inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are describeded, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

INHIBITORS OF BRUTON'S TYROSINE KINASE

-

Paragraph 1352; 1357, (2015/06/17)

Disclosed herein are reversible and irreversible inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are described, alone or in combination with other

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1791402-58-8